Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2010-05-27Clinical Trial Update: A Chinese Randomized Crossover Study of Erlotinib Versus Docetaxel/Cisplatin in Previously Untreated Stage IIIB/IV Lung Adenocarcinoma With EGFR Mutations [Phase 2]
A Phase 2 randomized crossover trial in untreated EGFR-mutant stage IIIB/IV lung adenocarcinoma compares erlotinib with docetaxel/cisplatin.
-
FDA approval · 2010-05-26FDA Approved: VINORELBINE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for Vinorelbine from Actavis Pharma, Inc., indicating an update to its labeling/indications.
-
CLINICAL_TRIALS trial_result · 2010-05-26Clinical Trial Update: Asymptomatic Brain Metastasis in Non-small Cell Lung Cancer (NSCLC) [Phase 3]
This Phase 3 clinical trial update concerns asymptomatic brain metastasis in non-small cell lung cancer, with the study status currently unk…
-
CLINICAL_TRIALS research · 2010-05-26Clinical Trial Update: The Continuation of Erlotinib [Phase 2]
A Phase 2 trial continuation of Erlotinib for non-small cell lung cancer is noted, with no results or status details provided.
-
CLINICAL_TRIALS trial_result · 2010-05-21Clinical Trial Update: A Study on the Long Term Survivals in an Expand Access Program (EAP) of Iressa [Phase 4]
A completed Phase 4 study in an expanded access program evaluating long-term survival in non-small cell lung cancer patients treated with Ir…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-05-17Clinical Trial Update: First Line IRESSA™ Versus Carboplatin/Paclitaxel in Asia [Phase 3]
A Phase 3 trial in Asia compared first-line gefitinib (IRESSA) with carboplatin/paclitaxel in non-small cell lung cancer, with results poste…
-
CLINICAL_TRIALS trial_result · 2010-05-17Clinical Trial Update: Adjuvant Vinorelbine Plus Cisplatin(NP) Versus NP Plus Endostar in Patients With Completely Resected Stage IB-IIIA Non-small Cell Lung Cancer(NSCLC) [Phase 3]
A Phase 3 trial comparing adjuvant Vinorelbine plus Cisplatin (NP) versus NP plus Endostar in patients with completely resected stage IB-III…
-
CLINICAL_TRIALS research · 2010-05-17Clinical Trial Update: Erlotinib Combined With Radiotherapy in Patients With Non-resectable Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC) [Phase 2]
Phase 2 trial evaluating erlotinib with radiotherapy in non-resectable locally advanced non-small cell lung cancer; status is UNKNOWN with n…
-
CLINICAL_TRIALS research · 2010-05-13Clinical Trial Update: Epidemiologic Study of KRAS Mutation in Brazilian Patients With Advanced or Metastatic Non Small Cell Lung Cancer
This clinical trial update describes an epidemiologic study examining KRAS mutations in Brazilian patients with advanced or metastatic non-s…
-
CLINICAL_TRIALS trial_result · 2010-05-10Clinical Trial Update: A Study Of SU011248 As Therapy In Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer [Phase 2]
Pfizer conducted a Phase 2 trial of SU011248 in locally advanced or metastatic non-small cell lung cancer; results from the completed study …
-
CLINICAL_TRIALS research · 2010-04-30Clinical Trial Update: Randomized Phase 2 Study of 3 Therapeutic Modalities in PS 2/3 Patients With NSCLC Stage IIIB/IV [Phase 2]
A randomized Phase 2 trial evaluated three therapeutic modalities in patients with stage IIIB/IV non-small cell lung cancer, and the study i…
-
CLINICAL_TRIALS trial_result · 2010-04-22Clinical Trial Update: Identification of Serum Markers For Tumor Hypoxia in Non-Small Cell Lung Cancers
This completed clinical trial from Stanford explored serum markers associated with tumor hypoxia in non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2010-04-20Clinical Trial Update: Molecular Profiling in Lung Cancer Patients [Phase 2]
Phase 2 clinical trial evaluating molecular profiling in non-small cell lung cancer patients has completed, with results posted in 2010.
-
CLINICAL_TRIALS research · 2010-04-16Clinical Trial Update: Radiofrequency Ablation Combined With Chemotherapy for Pulmonary Tumors
This clinical trial update discusses combining radiofrequency ablation with chemotherapy for pulmonary tumors, including non-small cell lung…
-
CLINICAL_TRIALS trial_result · 2010-04-12Clinical Trial Update: Phase II Study in Patients With Recurrent Non-Small-Cell Lung Cancer [Phase 2]
A Phase II trial in patients with recurrent non-small cell lung cancer has completed, according to a clinical trial update.
-
CLINICAL_TRIALS trial_result · 2010-04-09Clinical Trial Update: Carboplatin Plus Cetuximab for Treatment of Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial update evaluating the combination of carboplatin and cetuximab for Stage IIIB/IV non-small cell lung cancer. The study status …
-
CLINICAL_TRIALS trial_result · 2010-04-09Clinical Trial Update: Trial of Carboplatin/Paclitaxel/Cetuximab in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial of carboplatin/paclitaxel/cetuximab in stage IIIB/IV non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2010-04-09Clinical Trial Update: Study of Cetuximab in Combination With Carboplatin-Paclitaxel in Non-Small Cell Lung Cancer [Phase 1, Phase 2]
The Phase 1/2 trial of cetuximab in combination with carboplatin and paclitaxel for non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2010-04-08Clinical Trial Update: BAY43-9006 - Phase II Study in Non-Small Cell Lung Carcinoma (NSCLC) [Phase 2]
Phase II trial of BAY 43-9006 (sorafenib) in non-small cell lung cancer has completed. Results were posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-04-06Clinical Trial Update: A Study of Bevacizumab Plus Carboplatin and Paclitaxel in Subjects With Advanced, Previously Untreated, Squamous Non-Small Cell Lung Cancer (BRIDGE) [Phase 2]
Phase 2 study of bevacizumab plus carboplatin and paclitaxel in advanced, previously untreated squamous non-small cell lung cancer has compl…
-
CLINICAL_TRIALS trial_result · 2010-03-30Clinical Trial Update: Chemotherapy for Patients With Non-Small Cell Lung Cancer (NSCLC) [Phase 3]
Phase 3 clinical trial results for chemotherapy in non-small cell lung cancer were posted.
-
CLINICAL_TRIALS trial_result · 2010-03-29Clinical Trial Update: Pemetrexed Disodium and Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating the combination of pemetrexed disodium and erlotinib for advanced non-small cell lung cancer; the study …
-
EMA withdrawal · 2010-03-26EMA Application withdrawn: Docetaxel Mylan (docetaxel) — Mylan S.A.S.
Withdrawal of the EMA application for Docetaxel Mylan (docetaxel) by Mylan S.A.S., affecting multiple solid tumor indications including non-…
-
CLINICAL_TRIALS trial_result · 2010-03-24Clinical Trial Update: An Open Label Study of a Peptide Vaccine in Patients With Stage IIb or IIIa Non-Small Cell Lung Cancer [Phase 1]
Open-label Phase 1 study of a peptide vaccine in patients with stage IIb/IIIa non-small cell lung cancer; the trial sponsored by Epimmune is…
-
CLINICAL_TRIALS trial_result · 2010-03-17Clinical Trial Update: Pazopanib As Pre-Surgical Therapy In Treatment-Naive Subjects With Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating pazopanib as pre-surgical therapy in treatment-naive non-small cell lung cancer patients; results were posted after…